TrialThe Journal of clinical endocrinology and metabolism2020

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.

Felicia Cosman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.